[1]邵毅,谭思文,肖昂.视网膜中央动脉阻塞诊疗规范:2021美国心脏协会指南解读[J].眼科新进展,2021,41(10):901-904.[doi:10.13389/j.cnki.rao.2021.0189]
 SHAO Yi,TAN Siwen,XIAO Ang.Diagnosis and treatment of central retinal artery occlusion: interpretation of American Heart Association scientific statement 2021[J].Recent Advances in Ophthalmology,2021,41(10):901-904.[doi:10.13389/j.cnki.rao.2021.0189]
点击复制

视网膜中央动脉阻塞诊疗规范:2021美国心脏协会指南解读/HTML
分享到:

《眼科新进展》[ISSN:1003-5141/CN:41-1105/R]

卷:
41卷
期数:
2021年10期
页码:
901-904
栏目:
述评
出版日期:
2021-10-05

文章信息/Info

Title:
Diagnosis and treatment of central retinal artery occlusion: interpretation of American Heart Association scientific statement 2021
作者:
邵毅谭思文肖昂
330006 江西省南昌市,南昌大学第一附属医院眼科
Author(s):
SHAO YiTAN SiwenXIAO Ang
Department of Ophthalmology,the First Affiliated Hospital of Nanchang University,Nanchang 330006,Jiangxi Province,China
关键词:
视网膜中央动脉阻塞诊断治疗指南
Keywords:
central retinal artery occlusion diagnosis treatment scientific statement
分类号:
R774
DOI:
10.13389/j.cnki.rao.2021.0189
文献标志码:
A
摘要:
美国心脏协会近期发布的2021年“视网膜中央动脉阻塞诊疗规范”,对视网膜中央动脉阻塞的定义、流行病学、危险因素、病理生理、诊断与治疗等做了详细介绍,本文将对该指南进行全面解读。
Abstract:
American Heart Association (AHA) recently issued 2021 scientific statement “Management of Central Retinal Artery Occlusion (CRAO)”, which gives a detailed introduction to the definition, epidemiology, risk factors, pathophysiology, diagnosis and treatment of CRAO. In this paper, a comprehensive interpretation of this scientific statement will be made.

参考文献/References:

[1] SACCO R L,KASNER S E,BRODERICK J P,CAPLAN L R,CONNORS J J,CULEBRAS A,et al.An updated definition of stroke for the 21st century:a statement for healthcare professionals from the American Heart Association/American Stroke Association[J].Stroke,2013,44(7):2064-2089.
[2] LEAVITT J A,LARSON T A,HODGE D O,GULLERUD R E.The incidence of central retinal artery occlusion in Olmsted County,Minnesota[J].Am J Ophthalmol,2011,152(5):820-823.
[3] PARK S J,CHOI N K,PARK K H,WOO S J.Nationwide incidence of clinically diagnosed retinal vein occlusion in Korea,2008 through 2011:preponderance of women and the impact of aging[J].Ophthalmology,2014,121(6):1274-1280.
[4] KIDO A,TAMURA H,IKEDA H O,MIYAKE M,HIRAGI S,TSUJIKAWA A.Nationwide incidence of central retinal artery occlusion in Japan:an exploratory descriptive study using the National Database of Health Insurance Claims (2011-2015)[J].BMJ Open,2020,10(9):e041104.
[5] FLAXEL C J,ADELMAN R A,BAILEY S T,FAWZI A,LIM J I,VEMULAKONDA G A,et al.Retinal and ophthalmic artery occlusions preferred practice pattern[J].Ophthalmology,2020,127(2):259-287.
[6] ANDERSON D C,KAPPELLE L J,ELIASZIW M,BABIKIAN V L,PEARCE L A,BARNETT H J M.Occurrence of hemispheric and retinal ischemia in atrial fibrillation compared with carotid stenosis[J].Stroke,2002,33(8):1963-1967.
[7] PATRICK L,MORGAN P,MATTHEW H,ESPAILLAT K B,KIRSHNER H,SCHRAG M.Stroke risk and risk factors in patients with central retinal artery occlusion[J].Am J Ophthalmol,2018,196:96-100.
[8] CALLIZO J,FELTGEN N,PANTENBURG S,WOLF A,NEUBAUER A S,JURKLIES B,et al.Cardiovascular risk factors in central retinal artery occlusion:results of a prospective and standardized medical examination[J].Ophthalmology,2015,122(9):1881-1888.
[9] HAYREH S S,PODHAJSKY P A,ZIMMERMAN M B.Retinal artery occlusion:associated systemic and ophthalmic abnormalities[J].Ophthalmology,2009,116(10):1928-1936.
[10] 张鹏,王海燕,张自峰,王雨生.血栓危险因素与视网膜中央静脉阻塞的相关性[J].眼科,2013,22(6):393-396.
ZHANG P,WANG H Y,ZHANG Z F,WANG Y S.Clinical observation on the association between risk factors related to thrombus and central retinal vein occlusion[J].Ophthalmol CHN,2013,22(6):393-396.
[11] 王润生,吕沛霖,王宾,万雅群,雷晓琴.视网膜中央动脉阻塞患者视网膜循环时间与中心视力损害的关系[J].中华眼底病杂志,2007,23(3):177-179.
WANG R S,L P L,WANG B,WAN Y Q,LEI X Q.Relationship between retinal circulation time and visual loss in patients with central retinal artery occlusion[J].Chin J Ocul Fundus Dis,2007,23(3):177-179.
[12] HAYREH S S,JONAS J B.Optic disk and retinal nerve fiber layer damage after transient central retinal artery occlusion:An experimental study in rhesus monkeys[J].Am J Ophthalmol,2000,129(6):786-795.
[13] 赵珈珊,张惠蓉.视网膜中央动脉阻塞病因和视力预后分析[J].实用眼科杂志,1990,8(12):720-724.
ZHAO J S,ZHANG H R.The analysis of pathogenesis and visual prognosis in central retinal artery occlusion[J].Chin J Pract Ophthalmol,1990,8(12):720-724.
[14] WEYAND C M,GORONZY J J.Immune mechanisms in medium and large-vessel vasculitis[J].Nat Rev Rheumatol,2013,9(12):731-740.
[15] HAYREH S S.Ocular vascular occlusive disorders:natural history of visual outcome[J].Prog Retin Eye Res,2014,41:1-25.
[16] 彭晶莹,张军军,蒋小爽,李锐锋,李玲.睫状视网膜动脉与视网膜中央动脉阻塞患者中心视力损害的相关性分析[J].实用临床医药杂志,2017,21(7):102-104.
PENG J Y,ZHANG J J,JIANG X S,LI R F,LI L.Correlation between cilioretinal artery and central visual impairment in patients with central retinal artery occlusion[J].J Clin Med Pract,2017,21(7):102-104.
[17] 李梅,凌运兰,刘杏,冯官光,易长贤,郑小平.视网膜中央动脉阻塞性缺血对黄斑区视网膜神经上皮的影响[J].中国病理生理杂志,2001,17(8):749-751.
LI M,LIN Y L,LIU X,FENG G G,YI C X,ZHENG X P.Effect of central retinal artery occlusion on retinal microstructure of macula in vivo[J].Chin J Pathophysiol,2001,17(8):749-751.
[18] 刘杏,凌运兰,李梅,黄晶晶,郑小平.视网膜中央动脉阻塞的光相干断层扫描病理形态学改变[J].中华眼底病杂志,2005,21(2):10-14.
LIU X,LIN Y L,LI M,HUANG J J,ZHENG X P.The pathological changes of central retinal artery occlusion with Optical coherence tomography[J].Chin J Ocul Fundus Dis,2005,21(2):10-14.
[19] CASTRO-ABEGER A H,CARLO T E,DUKER J S,BAUMAL C R.Optical coherence tomography angiography compared to fluorescein angiography in branch retinal artery occlusion[J].Ophthalmic Surg Lasers Imaging Retina,2015,46(10):1052-1054.
[20] GRORY B M,LAVIN P,KIRSHNER H,SCHRAG M.Thrombolytic therapy for acute central retinal artery occlusion[J].Stroke,2020,51(2):687-695.
[21] HELLMICH B,AGUEDA A,MONTI S,BUTTGEREIT F,BOYSSON H,BROUWER E,et al.2018 Update of the EULAR recommendations for the management of large vessel vasculitis[J].Ann Rheum Dis,2020,79(1):19-30.
[22] 刘岩.视网膜中央动脉阻塞的诊断与治疗[J].中国医药指南,2014,12(9):131-133.
LIU Y.Diagnosis and treatment of central retinal artery occlusion[J].Guide CHN Med,2014,12(9):131-133.
[23] WARDLAW J M,MURRAY V,BERGE E,ZOPPO G J.Thrombolysis for acute ischaemic stroke.The Cochrane database of systematic reviews[J].Cochrane Database Syst Rev,2014,2014(7):CD000213.
[24] SCHORR E M,ROSSI K C,STEIN L K,PARK B L,TUHRIM S,DHAMOON M S.Characteristics and outcomes of retinal artery occlusion:nationally representative data[J].Stroke,2020,51(3):800-807.
[25] 田锦林,杜亚辉,罗军,李春雷,张林医.视网膜中央动脉阻塞:超选择性眼动脉溶栓与保守治疗的效果比较[J].中国介入影像与治疗学,2010,7(4):367-369.
TIAN J L,DU Y H,LUO J,LI C L,ZHANG L Y.Comparison of superselective ophthalmic artery fibrinolysis and conservative methods in treatment of central retinal artery occlusion[J].Chin J Interv Imaging Ther,2010,7(4):367-369.
[26] HAKIM N,HAKIM J.Intra-arterial thrombolysis for central retinal artery occlusion[J].Clin Ophthalmol,2019,13:2489-2509.
[27] 吴航,刘大川,吉训明,张旭香,杨慧清,宫丽萍,等.视网膜中央动脉阻塞介入溶栓治疗前后视网膜组织形态学改变[J].眼科新进展,2011,31(5):441-444.
WU H,LIU D C, JI X M,ZHANG X X,YANG H Q,GONG L P,et al.Retinal morphological changes in central retinal artery occlusion after intra-arterial thrombolysis treatment[J].Rec Adv Ophthalmol,2011,31(5):441-444.
[28] ZANATY M,BARROS G,CHALOUHI N,STARKE R M,MANASSEH P,TJOUMAKARIS S I,et al.Update on intra-arterial chemotherapy for retinoblastoma[J].Scientific World J,2014,2014:869604.
[29] 黄明海.视网膜中央动脉阻塞的临床治疗研究进展[J].国外医学(眼科学分册),2004,28(4):261-264.
HUANG M H.Progress in clinical treatment of central retinal artery occlusion[J].Section Ophthalmol Foreign Med Sci,2004,28(4):261-264.
[30] RUDKIN A K,LEE A W,CHEN C S.Ocular neovascularization following central retinal artery occlusion:prevalence and timing of onset[J].Eur J Ophthalmol,2010,20(6):1042-1046.
[31] KERNAN W N,OVBIAGELE B,BLACK H R,BRAVATA D M,CHIMOWITZ M I,EZEKOWITZ M D,et al.Guidelines for the prevention of stroke in patients with stroke and transient ischemic attack:a guideline for healthcare professionals from the American Heart Association/American Stroke Association[J].Stroke,2014,45(7):2160-2236.
[32] ARNOLD A C.Urgent evaluation of the patient with acute central retinal artery occlusion[J].Am J Ophthalmol,2018,196:16-17.

相似文献/References:

[1]杨红 阴正勤.眼球震颤的诊断与治疗研究进展[J].眼科新进展,2012,32(5):000.
[2]史大领 王殿强.棘阿米巴性角膜炎的临床特点及诊断[J].眼科新进展,2013,33(6):000.
[3]阎慧,赵少贞.干眼症临床检查的新进展[J].眼科新进展,2008,28(9):000.
[4]陈 彧 赵建民 王夏红 何文龙 张慧敏.视神经脊髓炎的视觉诱发电位和MRI对照研究[J].眼科新进展,2008,28(9):000.
[5]吴小军 高丰 赵青 周媛媛.rt-PA静脉溶栓联合复方樟柳碱治疗视网膜中央动脉阻塞的疗效观察[J].眼科新进展,2013,33(4):000.
[6]李伟,张奕霞.光学相干断层扫描在视网膜中央动脉阻塞上的诊断价值[J].眼科新进展,2016,36(4):345.[doi:10.13389/j.cnki.rao.2016.0093]
 LI Wei,ZHANG Yi-Xia.Diagnostic values of OCT for central retinal artery occlusion[J].Recent Advances in Ophthalmology,2016,36(10):345.[doi:10.13389/j.cnki.rao.2016.0093]
[7]石路漫,雷方,陈彬川,等.白内障超声乳化吸出术后视网膜中央动脉阻塞风险因素分析[J].眼科新进展,2016,36(11):1047.[doi:10.13389/j.cnki.rao.2016.0279]
 SHI Lu-Man,LEI Fang,CHEN Bin-Chuan,et al.Risk factors of central retinal artery occlusion after phacoemulsification[J].Recent Advances in Ophthalmology,2016,36(10):1047.[doi:10.13389/j.cnki.rao.2016.0279]
[8]孙飒,张俊杰.抑郁症与干眼关系研究进展[J].眼科新进展,2016,36(11):1090.[doi:10.13389/j.cnki.rao.2016.0291]
 SUN Sa,ZHANG Jun-Ji.Research advances in relationship between depression and dry eye[J].Recent Advances in Ophthalmology,2016,36(10):1090.[doi:10.13389/j.cnki.rao.2016.0291]
[9]赵晓金,丁相奇,钱立峰.白内障超声乳化吸出术后缺血性眼病的临床研究[J].眼科新进展,2017,37(2):172.[doi:10.13389/j.cnki.rao.2017.0045]
 ZHAO Xiao-Jin,DING Xiang-Qi,QIAN Li-Feng.Clinical analysis of ischemic ophthalmopathy after cataract phacoemulsification[J].Recent Advances in Ophthalmology,2017,37(10):172.[doi:10.13389/j.cnki.rao.2017.0045]
[10]王镇,谭晓俊,程钧,等.药物性角膜炎的研究进展[J].眼科新进展,2017,37(2):192.[doi:10.13389/j.cnki.rao.2017.0050]
 WANG Zhen,TAN Xiao-Jun,CHENG Jun,et al.Research advances in toxic keratopathy[J].Recent Advances in Ophthalmology,2017,37(10):192.[doi:10.13389/j.cnki.rao.2017.0050]

备注/Memo

备注/Memo:
中央引导地方科技发展资金(编号:20211ZDG02003);江西省杰出青年人才计划(20192BCBL23020);江西省重点研发项目(编号: 20181BBG70004,20203BBG73059)
更新日期/Last Update: 2021-10-05